PATENT CLAIM ANALYSIS

Application Number: 16060659
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "552000"]

Abstract:
The invention provides a pro-resolving mediator for use in the reduction of reactogenicity induced by administration of a vaccine or immunogenic composition comprising at least an antigen, and vaccines or immunogenic compositions comprising such a pro-resolving mediator.

Claim (Index 20):
The method of  claim 19  wherein, the adjuvant is selected from the group consisting of: an oil-in-water emulsion (for example MF59 or AS03), liposomes, a saponin, a TLR2 agonist, a TLR3 agonist, TLR4 agonist, TLR5 agonist, TLR6 agonist, TLR7 agonist, TLR8 agonist, TLR9 agonist, aluminium salts, microparticles, ISCOMS, calcium fluoride composites or any combination of two or more thereof.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 94.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12103136', '12596202', '13020045', '15446508', '15354233']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7564596533161304
- 35 USC 102 Novelty (BERT): 0.5212636749001494
- Combined Prediction Score: 0.7329400554745323
- Mean Citation Score: 223.322114
- Max Citation Score: 239.91882
- Similarity Product: 132.14569053416133

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test